Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: "Strategic Partnership"? milestone
2
Jan 23, 2008 06:53AM

Re: "Strategic Partnership"? milestone

posted on Jan 23, 2008 11:41AM

TPL could then offer other infringing companies a wider variety of products to license while still offering the MMP.  And still pay Patriot our half of the MMP license money.  Maybe a discount if infringing companies bundle licenses

 

I ask again, where's the benefit to PTSC in that arrangement? TPL are receiving a percentage of any J patents licensed but PTSC would only receive 50% of PDS income. Also, PTSC would be losing income due the fact that TPL are discounting the MMP Portfolio to licensees signing for the full package.

 

 

Be well

Share
New Message
Please login to post a reply